DEVELOPMENT OF A HYBRID ARTIFICIAL ORGAN

Information

  • Research Project
  • 3502202
  • ApplicationId
    3502202
  • Core Project Number
    R43HL048001
  • Full Project Number
    1R43HL048001-01A1
  • Serial Number
    48001
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/30/1992 - 32 years ago
  • Project End Date
    3/31/1993 - 31 years ago
  • Program Officer Name
  • Budget Start Date
    9/30/1992 - 32 years ago
  • Budget End Date
    3/31/1993 - 31 years ago
  • Fiscal Year
    1992
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    9/30/1992 - 32 years ago

DEVELOPMENT OF A HYBRID ARTIFICIAL ORGAN

The goal of this study is to determine the feasibility of using a dense, semipermeable polymer membrane for immuno-isolation of foreign tissue in a hybrid artificial organ. A series of polymers will be synthesized and characterized for permeability, cytotoxicity and biostability. The polymer composition/morphology will be varied to yield a series of polymers with stepwise increasing permeability. Membranes will be cast from solution onto release liner, using a laboratory web coater under uniform conditions of air flow and thermal history. The same casting solution will be used to prepare small-diameter, hollow-fiber membranes for use as cell packets for mouse implant and in vitro cell growth experiments. Using a series of permanent solutions, the permeability of the flat membranes to water, glucose and several proteins will be measured in a non-steady-state diffusion experiment. Sensitive calorimetric/staining methods will be used to quantify glucose and proteins which permeate the membranes for calculation of permeability coefficients for selected permanent/membrane pairs. In Phase II we will build and implant hybrid organs with protective, selectively-permeable barriers for cultured and/or genetically engineered cells. In Phase III the membranes developed in Phase II will be offered commercially by our licensee as (components of) hybrid artificial organs.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R43
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    SSS
  • Study Section Name
  • Organization Name
    POLYMER TECHNOLOGY GROUP, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    BERKELEY
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    94710
  • Organization District
    UNITED STATES